UiPath (NYSE:PATH) Trading 0.2% Higher

UiPath Inc. (NYSE:PATHGet Free Report) traded up 0.2% on Monday . The company traded as high as $23.23 and last traded at $23.01. 1,513,100 shares traded hands during trading, a decline of 84% from the average session volume of 9,727,845 shares. The stock had previously closed at $22.97.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Canaccord Genuity Group lifted their price objective on UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. TD Cowen lifted their price target on UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, March 14th. Wells Fargo & Company lifted their price target on UiPath from $24.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Truist Financial restated a “buy” rating and issued a $32.00 price target on shares of UiPath in a research note on Wednesday, March 20th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $29.00 price target on shares of UiPath in a research note on Wednesday, March 20th. Nine research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, UiPath presently has a consensus rating of “Hold” and a consensus target price of $27.44.

Get Our Latest Report on PATH

UiPath Trading Down 1.6 %

The company has a fifty day moving average price of $23.61 and a two-hundred day moving average price of $21.02.

Insider Activity at UiPath

In related news, Director Rich Wong sold 200,000 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $23.12, for a total value of $4,624,000.00. Following the transaction, the director now directly owns 429,418 shares in the company, valued at $9,928,144.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Rich Wong sold 200,000 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $23.12, for a total value of $4,624,000.00. Following the transaction, the director now directly owns 429,418 shares in the company, valued at $9,928,144.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ashim Gupta sold 70,000 shares of the business’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $23.02, for a total value of $1,611,400.00. Following the completion of the sale, the chief financial officer now directly owns 788,148 shares in the company, valued at approximately $18,143,166.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 427,000 shares of company stock worth $9,784,110. Insiders own 31.03% of the company’s stock.

Institutional Trading of UiPath

Several hedge funds have recently modified their holdings of the stock. Norges Bank purchased a new position in shares of UiPath during the fourth quarter worth about $165,749,000. BlackRock Inc. raised its holdings in UiPath by 32.1% in the 2nd quarter. BlackRock Inc. now owns 23,376,854 shares of the healthcare company’s stock valued at $387,354,000 after acquiring an additional 5,681,577 shares during the last quarter. Altimeter Capital Management LP grew its stake in shares of UiPath by 175.4% during the 1st quarter. Altimeter Capital Management LP now owns 8,275,000 shares of the healthcare company’s stock valued at $71,579,000 after buying an additional 5,270,194 shares during the period. Senvest Management LLC grew its stake in shares of UiPath by 188.4% during the 2nd quarter. Senvest Management LLC now owns 6,027,933 shares of the healthcare company’s stock valued at $99,883,000 after buying an additional 3,937,951 shares during the period. Finally, Millennium Management LLC grew its stake in shares of UiPath by 899.5% during the 4th quarter. Millennium Management LLC now owns 4,049,999 shares of the healthcare company’s stock valued at $51,475,000 after buying an additional 3,644,799 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.